Pharma-Bio Serv, Inc. Reports Earnings Results for the Year Ended October 31, 2018
January 29, 2019 at 05:03 pm EST
Share
Pharma-Bio Serv, Inc. reported earnings results for the year ended October 31, 2018. The company’s net revenues from continuing operations for the year ended October 2018 were $17.8 million, an increase of $4.5 million, or 34%, when compared to last year. Net income was approximately $1.3 million, an increase in net earnings of $2.7 million, when compared to last year.
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
PHARMA-BIO SERV, INC. 
